Late-onset hematological complications post COVID-19: An emerging medical problem for the hematologist.
Am J Hematol
; 97(1): 119-128, 2022 01 01.
Article
in English
| MEDLINE | ID: covidwho-1479374
ABSTRACT
Coronavirus disease 19 (COVID-19) is considered a multisystemic disease. Several studies have reported persistent symptoms or late-onset complications after acute COVID-19, including post-COVID-19 hematological disorders. COVID-19-induced coagulopathy, an immunothrombotic state, has been linked to thromboembolic and hemorrhagic events. Late-onset thrombocytopenia related to immune system dysregulation has also been reported as a rare manifestation post COVID-19. Close monitoring of laboratory dynamics is considered essential to identify timely abnormal values that need further investigation, providing supportive care whenever indicated. The role of hematologists is essential in terms of the multidisciplinary approach of long COVID-19. This review summarizes all the available evidence on post-acute COVID-19 hematological complications.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Hematologic Diseases
Topics:
Long Covid
Limits:
Animals
/
Humans
Language:
English
Journal:
Am J Hematol
Year:
2022
Document Type:
Article
Affiliation country:
Ajh.26384
Similar
MEDLINE
...
LILACS
LIS